Narrative review and pooled analysis of STAR for refractory VT reports 16% 6-month and 33% 12-month mortality, 75% VT burden reduction at 6 months, and 7% grade 3+ toxicities, with high heterogeneity.
Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA -MI-VT phase Ib/II study
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
physics.med-ph 1years
2025 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
Stereotactic Arrhythmia Radioablation for Refractory Ventricular Tachycardia: A Narrative Review and Exploratory Pooled Analysis of Clinical Outcomes and Toxicity
Narrative review and pooled analysis of STAR for refractory VT reports 16% 6-month and 33% 12-month mortality, 75% VT burden reduction at 6 months, and 7% grade 3+ toxicities, with high heterogeneity.